Skip to content

Serotonin: all studies

Page 373 of 400: studies 3,721 to 3,730 of 3,999, newest first. Back to the serotonin overview

Research

Possible mechanisms of panic attack and schizophrenia via APUD system.

Medical Hypotheses February 2002 K Fukuda

Psilocybin poisoning produces biphasic reactions composed of a schizophrenic phase and a panic attack-like phase. There is a time lag of several hours between phases, which may be considered an accumulation time in certain sites between the gut and the brain. So far as 5-hydroxytryptamine (5-HT) congeners are concerned, no sites are to be found except the amine precursor uptake and...

Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use

Human Psychopharmacology: Clinical and Experimental December 1, 2001 Jörg Daumann, Susanna Pelz, Stefanie Becker et al. 77 citations

Abstract The popular recreational drug Ecstasy (3,4‐methylenedioxymethamphetamine, or MDMA, and related congeners) is neurotoxic upon central serotonergic systems in animal studies. So far, the most convincing evidence for neurotoxicity‐related functional deficits in humans derives from neurocognitive studies demonstrating dose‐related memory problems in Ecstasy users. The aim of the current...

Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach

Human Psychopharmacology: Clinical and Experimental December 1, 2001 Liesbeth Reneman, Jan Booij, Charles B.l.m. Majoie et al. 50 citations

Abstract Human users of 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) users may be at risk of developing MDMA‐induced neuronal injury. Previously, no methods were available for directly evaluating the neurotoxic effects of MDMA in the living human brain. However, development of in vivo neuroimaging tools has begun to provide insights into the effects of MDMA in the human brain. In this...

DOI: 10.1002/hup.347 (opens in new tab) MDMA Ecstasy Neurotoxicity Hallucinogen +2

A systems model of altered consciousness: integrating natural and drug-induced psychoses.

Brain Research Bulletin November 15, 2001 Franz X. Vollenweider, Mark A. Geyer

Increasing evidence from neuroimaging and behavioral studies suggests that functional disturbances within cortico-striato-thalamic pathways are critical to psychotic symptom formation in drug-induced and possibly also naturally occurring psychoses. Recent basic and clinical research with psychotomimetic drugs, such as the N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, ketamine, and...

Fatalities Caused by the MDMA-Related Drug Paramethoxyamphetamine (PMA)

Journal of Analytical Toxicology October 1, 2001 James C. Kraner, Damon Mccoy, Mark A. Evans et al. 89 citations

The past several years have seen a marked increase in the recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or "Ecstasy". MDMA use is especially common among young people participating in dance parties called "raves". Paramethoxyamphetamine (PMA) exhibits both structural and pharmacological similarity to MDMA. It may, however, be a more potent central stimulant, particularly in its...

‘Imagery Rehearsal’ Can Control PTSD-Related Nightmares

Psychiatric News September 21, 2001 Joan Arehart-Treichel

Back to table of contents Previous article Next article Clinical & Research NewsFull Access'Imagery Rehearsal' Can Control PTSD-Related NightmaresJoan Arehart-TreichelJoan Arehart-TreichelPublished Online:21 Sep 2001https://doi.org/10.1176/pn.36.18.0023In 1994, a Wyoming native—"Tom"—was hiking in the backcountry of Yellowstone National Park when an 800-pound grizzly bear tackled him and...

Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates

Pharmacogenetics August 1, 2001 Yamini Ramamoorthy, Rachel F. Tyndale, Edward M. Sellers 92 citations

CYP2D6 is involved in the metabolism of several classes of drugs, including tricyclic antidepressants, selective serotonin reuptake inhibitors and various amphetamines. CYP2D6*10 is an allelic variant, producing an enzyme with Pro34Ser and Ser486Thr amino acid substitutions. Approximately 75% of Asians possess the *10 allele. We sought to further characterize CYP2D6.10 catalytically in vitro in...

DOI: 10.1097/00008571-200108000-00003 (opens in new tab) MDMA Cyp2d6 Dextromethorphan Debrisoquine +7

Psychointegrators: Multidisciplinary Perspectives on the Therapeutic Effects of Hallucinogens

Complementary health practice review July 1, 2001 Michael Winkelman 22 citations

Vision-inducing plants ("hallucinogens") are important in many societies, evoking powerful emotional, psychological, cognitive, religious, spiritual, therapeutic and political reactions. These substances' psychophysiological properties shape cross- cultural similarities in patterns of use and experiences, while political factors shape their cultural desirability. Neurological studies illustrate...

SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects.

Journal of Sleep Research June 1, 2001 Edward F Pace-Schott, T Gersh, R Silvestri et al.

Clinical lore and a small number of published studies report that the selective serotonin reuptake inhibitors (SSRIs) intensify dreaming. This study examines the dream effects of paroxetine and fluvoxamine in order to both increase clinical knowledge of these agents and to test an important potential method for probing the relationship between REM sleep neurobiology and dreaming in humans....

Vascular actions of MDMA involve α1 and α2‐adrenoceptors in the anaesthetized rat

British Journal of Pharmacology June 1, 2001 John Mcdaid, James R. Docherty 46 citations

We have investigated the effects of methylenedioxymethamphetamine (MDMA, ‘ecstasy’), i.v., on diastolic blood pressure (DBP) in pithed and pentobarbitone anaesthetized rats. In pithed rats, the non‐selective 5‐HT receptor antagonist methiothepin (0.1 mg kg −1 ) and the α 2 ‐adrenoceptor antagonists methoxyidazoxan and yohimbine (1 mg kg −1 ) showed significant α 1 ‐adrenoceptor antagonist...

DOI: 10.1038/sj.bjp.0704094 (opens in new tab) Ritanserin Prazosin Yohimbine Endocrinology +4